← Back
$KROS All transactions

Keros Therapeutics, Inc.

A

$ Value

$0

Shares

13,215

Price

$0

Filed

Mar 11

Insider

Name

Newton Charles W.

Title

CIK

0001866219

Roles

Director

Transaction Details

Transaction Date

2026-03-09

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,215

Footnotes

Represents a restricted stock unit ("RSU") award. The RSUs shall vest over a three-year period in twelve equal quarterly installments with the first such vesting to occur on May 15, 2026, subject to the Reporting Person's continuous service through each such vesting date. | The shares subject to the option shall vest over a three-year period in equal quarterly installments with the first such vesting to occur on June 9, 2026, subject to the Reporting Person's continuous service through each such vesting date.

Filing Info

Accession No.

0001866219-26-000005

Form Type

4

Issuer CIK

0001664710

Newton Charles W.'s History

Date Ticker Type Value
2026-03-09 KROS A $0
2026-03-09 KROS A $0
2025-08-20 LYEL A $0
2025-06-12 CHRS A $0
2025-05-13 TSVT D
2025-05-13 TSVT U
2025-05-13 TSVT D
2025-05-13 TSVT D
2025-04-25 NVAX A $0
2025-04-25 NVAX A $0

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $34K 2026-04-15
Regnante Keith
CHIEF FINANCIAL OFFICER
$77K 2026-02-24
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
$113K 2026-04-02
Newton Charles W. 2026-03-09
Lerner Lorena Raquel
Chief Science Officer
$63K 2026-02-18
Lerner Lorena Raquel
Chief Scientific Officer
2026-02-24
Cho Esther
Chief Legal Officer
2026-02-24
Cho Esther
SVP, General Counsel
$78K 2026-02-18